Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Apr;14(2):101-10.
doi: 10.1007/s11920-012-0258-y.

Evaluation and treatment of children and adolescents with psychotic symptoms

Affiliations
Review

Evaluation and treatment of children and adolescents with psychotic symptoms

Sibel Algon et al. Curr Psychiatry Rep. 2012 Apr.

Abstract

In recent years, there have been increasing efforts to develop early detection and prevention strategies for patients at risk of the development of psychotic disorders. These efforts have led to improved recognition and characterization of psychotic symptoms in youth. This review focuses on the evaluation of children and adolescents with psychotic symptoms who are experiencing functional impairment but who do not meet current criteria for schizophrenia. For this article, emphasis is placed on the evaluation of symptoms, differential diagnosis, and consideration of potential interventions.

PubMed Disclaimer

Conflict of interest statement

Disclosure No potential conflicts of interest relevant to this article were reported.

References

    1. Gearing RE. Evidence-based family psychoeducational interventions for children and adolescents with psychotic disorders. J Can Acad Child Adolesc Psychiatry. 2008;17(1) - PMC - PubMed
    1. Masi G, Liboni F. Management of schizophrenia in children and adolescents: focus on pharmacotherapy. Drugs. 2011;71(2):179–208. In this systematic review, the authors offer a comprehensive overview of available literature on pharmacologic interventions for childhood-onset schizophrenia. The authors summarize limitations in several aspects of current pharmacotherapy, including low effect size, high rates of adverse effects, and low rates of remission. They highlight the need for further research with both randomized, placebo-controlled studies and long-term, naturalistic follow-up of large samples of patients with different age ranges. - PubMed
    1. Simon AE, et al. Defining subjects at risk for psychosis: a comparison of two approaches. Schizophr Res. 2006;81(1):83–90. - PubMed
    1. Miller TJ, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159(5):863–5. - PubMed
    1. Klosterkotter J, et al. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58(2):158–64. - PubMed

Publication types

Substances